Read the latest news from Saama.
CAMPBELL, Calif. April 30, 2024 – Saama, a leader of AI-based clinical trial solutions and services that accelerate drug development and commercialization, is pleased to
CAMPBELL, Calif., February 20, 2024 – Saama today announced the appointment of Bhaskar Sambasivan as Chief Executive Officer. Sambasivan succeeds Vivek Sharma, who is stepping
CAMPBELL, Calif., February 12, 2024 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced a newly expanded, multi-year agreement with global
CAMPBELL, Calif.–(BUSINESS WIRE)–Today, Saama announced the release of several groundbreaking features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL),
December 13, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, is pleased to share that Lisa Moneymaker, the company’s
CAMPBELL, Calif., October 17, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced a multi-year agreement with global
September 19, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today introduced Data Quality (DQ) co-pilot, a feature embedded
CAMPBELL, Calif.–(BUSINESS WIRE)–Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced that it was named a Leader in the “Life
Suite of AI-enhanced SaaS solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time.
